Zeaxanthin More importance = Eyes/skin Absorption

If you want to be filled in more about Astaxanthin you could check out my earlier blogs on it.. This a review on mostly Zeaxanthin. See thing is Astaxanthin is actually much stronger than zeaxanthin… but, zeaxanthin tends to have better absorbsion in the eyes, skin and optic / auditory nerves making it much more effective in those areas..

If your eyesight is one of your priorities then consider zeaxanthin.. Perhaps through the many foods such as spinach, kale, eggs, turnip greens, collard greens, romaine lettuce, broccoli, zucchini, corn, garden peas and Brussels sprouts.. Although the problem lies in moderation..Its hard to say you’d get what you need from the food alone unless you have a prepared diet and stuck with it..

That’s often where the supplements come in.. I’ve tried Noagin, and can say it works well. Its a mix between Zeaxanthin, Astaxanthin, and Lutein. A concentrated formula for maintaining a healthy body, wrinkles, eyesight,memory, prevention of cancer, aswell as others. I’ve gone more into depth on a previous blog. They really are super antioxidants.

For any extra information check out this Video.

http://www.youtube.com/watch?v=thgdES75H2o

take care =D

Chemo Fails against Pancreatic Cancer..

Scientists have been investigating why hasen’t chemotherapy proved very effective in patients of pancreatic cancer.

In a recent study, published in the journal Science, researchers from Cancer Research UK may have uncovered the answer. The researchers studied the tumors in mice genetically engineered too develop prostate cancer(Kinda’ve harsh), finding that the tumors had only a slim network of blood vessels/in contrast to most tumors, which need a steady supply of blood for their growth and survival. When the researchers examined human prostate tumors, they saw that same pattern.

Researchers have hypothesized that chemotherapy drugs might have trouble reaching pancreatic tumors to affect them. The paucity of blood vessels in pancreatic tumors suggest that these tumors are a-bit less dependent on such a large blood supply. This, in turn, could explain why VEGF inhibitors, chemotherapy drugs that seek to cut off blood to tumors, so often prove ineffective in treating Pancreatic Cancer…

There are 230,000 new cases of pancreatic cancer each year, including 37,000 in the United States and 7,600 in the United Kingdom. It is one of the most lethal of cancers, due to spreading quickly. Because the cancer is often only detected in an advanced stage, surgical removal is often not likely.. Only 3% of pancreatic cancer patients are still alive five years after diagnosis

The researchers in the current study found, however, that pancreatic tumors responded significantly better to chemotherapy when the drug Gemzar was combined with the experimental drug IPI-926, manufactured by Infinity Pharmaceuticals.

“We’re extremely excited by these results as they may help explain the disappointing response that many pancreatic cancer patients receive from chemotherapydrugs,” researcher David Tuveson said. “But these are early days and we need to show this approach is safe to use in humans before we can consider adding the new compound to cancer treatments.”

dardon,

{block:Permalink}

blog comments powered by Disqus{/block:Permalink}